| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/18/2009 | CN101370782A Alkylsulphonamide quinolines |
| 02/18/2009 | CN101370522A Specific therapy using integrin ligands for treating cancer |
| 02/18/2009 | CN101370519A Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer |
| 02/18/2009 | CN101370512A Isolated organ perfusion combination therapy of cancer |
| 02/18/2009 | CN101370510A Anticancer agent comprising a peptide |
| 02/18/2009 | CN101370509A Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer |
| 02/18/2009 | CN101368187A Recombinant human FUS1 and human IL-12 dual-gene expression carrier, liposome complexes, preparation method and application thereof |
| 02/18/2009 | CN101368173A Antihuman CD44 monoclone antibody hybridoma cell line, monoclone antibody, engineering antibody, carrier, reagent kit and uses thereof |
| 02/18/2009 | CN101367883A Method for extracting glossy ganoderma polysaccharide from fermentation liquor |
| 02/18/2009 | CN101367881A High-efficiency preparation method for glossy ganoderma polysaccharide |
| 02/18/2009 | CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 02/18/2009 | CN101367871A Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 02/18/2009 | CN101367861A 2-hydroxyl-3-deoxidized pentacyclic triterpenoid and derivant, preparation method and uses thereof |
| 02/18/2009 | CN101367850A Norabieta cantharidin derivant and synthesis thereof |
| 02/18/2009 | CN101367841A Compound with latent antitumor effect and method of preparing the same |
| 02/18/2009 | CN101367834A Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/18/2009 | CN101367822A Novel dihydro arteannuin derivant, preparation method and uses as medicament |
| 02/18/2009 | CN101367820A Pyrazole-[1,5-a]indole fluoroform sulphonate-4-dimethylamino-benzyl alkene derivant and method of preparing the same |
| 02/18/2009 | CN101367819A 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof |
| 02/18/2009 | CN101367801A Preparation method for pyrrol-hexahydric N heterocycle hydroxyl morpholine derivants, and medical uses thereof |
| 02/18/2009 | CN101367794A Preparation method for quinazoline derivants and medical uses thereof |
| 02/18/2009 | CN101367793A Amino-quinazoline derivative with antineoplastic activity and its salts |
| 02/18/2009 | CN101367786A Preparation method of genistein nitric oxide donor type derivant and uses thereof |
| 02/18/2009 | CN101367775A Rhodanine derivant, preparation method and uses thereof |
| 02/18/2009 | CN101366950A Uses of gamma-ray combined phTERT-HRP/IAA in medicament for treating cancer of larynx |
| 02/18/2009 | CN101366933A Lung cancer treating medicine |
| 02/18/2009 | CN101366914A Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method |
| 02/18/2009 | CN101366885A Centipede ointment for treating skin cancer |
| 02/18/2009 | CN101366831A Rhubarb polyoses, preparation method, medicament composition and uses |
| 02/18/2009 | CN101366828A Capsule for treating cancer with centipede |
| 02/18/2009 | CN101366827A Manchurian walnut bark extract and preparation method thereof |
| 02/18/2009 | CN101366769A Medicament capsule for treating mazopathy |
| 02/18/2009 | CN101366737A Nano glossy ganoderma spore polypeptide product, preparation and application thereof |
| 02/18/2009 | CN101366733A Katsutoxin extract, preparation method and application thereof |
| 02/18/2009 | CN101366732A Preparation of full-natural centipede dry powder |
| 02/18/2009 | CN101366725A Tumour injection |
| 02/18/2009 | CN101366722A Hydrotalcite doxifluridine slow release formulation and preparation method thereof |
| 02/18/2009 | CN101366698A Biogastrone acid prosome liposome with long circulation function and preparation method thereof |
| 02/18/2009 | CN101366697A Novel nano-lipid carrier for injection embodying paclitaxel series substances and preparation method thereof |
| 02/18/2009 | CN101366696A Medicament composition for water-soluble injection of paclitaxel, preparation method and uses thereof |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/18/2009 | CN100462103C Cholesterol phosphononucleoside analogue |
| 02/18/2009 | CN100462076C Stabilized oil-in-water emulsion of vinca alkaloids for vein and production thereof |
| 02/18/2009 | CN100462073C Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
| 02/18/2009 | CN100462072C Medicine composition used for injection and its preparing method |
| 02/18/2009 | CN100462070C Retinoic acid release control nanomicrosphere and its preparation method |
| 02/18/2009 | CN100462066C Novel formulations of pharmacological agents, method for preparation thereof and method for use thereof |
| 02/17/2009 | US7491849 Oligoamine compounds and derivatives thereof for cancer therapy |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491802 Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491745 e.g. 2-Ethyl-11-((3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene)methyl)-10-azabicyclo[7.2.1]dodeca-9(12),11-diene; anticarcinogenic agent; antiproliferative agent, viricide; |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491728 Pyrimidinone compounds as calcilytics |
| 02/17/2009 | US7491707 Synthetic lipid-a-analogs and uses thereof |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |
| 02/17/2009 | US7491525 Specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 02/17/2009 | US7491514 High specificity antibodies with reduce immunogenicity; evaluative and diagnostic tools; immunotherapy |
| 02/17/2009 | US7491394 Using copper binding protein as therapeutic tool in prevention of viral infection and treatment of cell proliferative disorders |
| 02/17/2009 | CA2535806C The use of hdac inhibitors for the treatment of cancer |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2356087C Methods and compositions for treatment of cell proliferative disorders |
| 02/17/2009 | CA2346406C Detection of pleiotrophin |
| 02/17/2009 | CA2301874C Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 02/17/2009 | CA2282812C Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 02/17/2009 | CA2257010C Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/17/2009 | CA2157143C Alkylbenzoylguanidine derivatives |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/13/2009 | CA2597193A1 Compounds and uses |
| 02/12/2009 | WO2009021169A2 (7h-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 02/12/2009 | WO2009020990A1 2- [ (2-{phenylamino}-1h-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as igf-1r inhibitors for the treatment of cancer |
| 02/12/2009 | WO2009020964A2 Anti-neublastin antibodies and uses thereof |
| 02/12/2009 | WO2009020645A2 Matriptase protein and uses thereof |
| 02/12/2009 | WO2009020631A2 Compounds for treating proliferative disorders |
| 02/12/2009 | WO2009020590A1 Methods for treating lymphomas in certain patient populations and screening patients for said therapy |
| 02/12/2009 | WO2009020521A2 Identification and treatment of estrogen responsive prostate tumors |
| 02/12/2009 | WO2009020448A1 Proteasome inhibitors |
| 02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
| 02/12/2009 | WO2009020093A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | WO2009020028A1 Determination and suppression of expression level of g protein-coupled receptor kinase 4 gene in breast cancer cell |
| 02/12/2009 | WO2009019518A1 Pyrimidine compounds having a fgfr inhibitory effect |
| 02/12/2009 | WO2009019506A1 Heterocyclyc sulfonamides having edg-1 antagonistic activity |
| 02/12/2009 | WO2009019446A1 Compounds useful as medicaments |
| 02/12/2009 | WO2009019445A1 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 02/12/2009 | WO2009019317A1 Composition and therapeutic anti-tumour vaccine |
| 02/12/2009 | WO2009019312A2 Anti cd37 antibodies |
| 02/12/2009 | WO2009019286A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 02/12/2009 | WO2009019281A1 Benzoisoindole derivatives and their use as ep4 receptor agonists for the treatment of pain |
| 02/12/2009 | WO2009019274A1 Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53 |
| 02/12/2009 | WO2009019205A1 Crystalline form of a dihydropteridione derivative |
| 02/12/2009 | WO2009018811A1 Novel pharmaceuticals, method for the production thereof, and use thereof in medical therapy |
| 02/12/2009 | WO2009018780A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/12/2009 | WO2009018726A1 An antrodia camphorata cyclohexenone compound used for inhibiting hepatitis b virus |
| 02/12/2009 | WO2009018667A1 Plant bioreactor for the production of interleukin-24 cytokine |
| 02/12/2009 | WO2009018625A1 Treatment of prion protein related diseases |